AMM - Antidepressant Medication Management
Product Lines:
Advantage MD, Dual Eligible Special Needs Plans (D-SNP), EHP, Priority Partners and USFHP.
Eligible Population:
Members 18 years of age and older by December 31 of the measurement year.
Definition:
Measure evaluates percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication treatment.
Two rates are reported:
- Effective Acute Phase Treatment: percentage of members who remained on an antidepressant medication for at least 84 days (12 weeks)
- Effective Continuation Phase Treatment: percentage of members who remained on an antidepressant medication for at least 180 days (6 months)
Continuous Enrollment:
- 105 days prior to the IPSD* through 231 days after the IPSD.
Best Practice and Measure Tips
The American Psychiatric Association and The Substance Abuse and Mental Health Services Administration recommend patients complete the Patient Health Questionnaire (PHQ)-9 screening tool as needed. Consider the following if you diagnose the patient with depression and prescribe medication.
- Encourage them to attend psychotherapy.
- Let them know it can take several months for antidepressant medication to be effective.
- Remind them to continue their medication for at least six months.
- Give members written instructions to reinforce teaching about the proper use of medication and what to do if they experience side effects.
- Discuss other factors that may improve symptoms, such as aerobic exercise and counseling or therapy
- Follow up within 30 days from when prescribe medication is filled for any side effects and their response to treatment.
- For patients with complex conditions, consider referring them to a psychiatrist.
- Coordinate Care by sharing progress notes and updates with behavioral health provider.
- For Members who cancel or missed appointments, reach out to them and reschedule as soon as possible.
Measure Exclusions
Required Exclusion:
- Members in hospice or using hospice services anytime during the measurement year.
- Members who died any time during the measurement year.
- Members who did not have an encounter with a diagnosis of major depression during the 121-day period from 60 days prior to the Index prescription start date (IPSD), through the IPSD and the 60 days after the IPSD.
Measure Medications
Antidepressant Medications
Description | Prescription |
---|---|
Miscellaneous antidepressants |
|
Monoamine oxidase inhibitors |
|
Phenylpiperazine antidepressants |
|
Psychotherapeutic combinations |
|
SNRI antidepressants |
|
SSRI antidepressants |
|
Tetracyclic antidepressants |
|
Tricyclic antidepressants |
|